GSE220283 STAT3 knockdown Hep-G2 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE220283_STAT3 knockdown_Hep-G2_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE220283_STAT3 knockdown_Hep-G2_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE220283_STAT3 knockdown_Hep-G2_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE220283_STAT3 knockdown_Hep-G2_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

SRC kinase signaling inhibitor 1

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

PAX8 antisense RNA 1

Gene

double homeobox A pseudogene 8

Gene

CASTOR family member 3, pseudogene

Gene

MIR1915 host gene

Gene

colorectal neoplasia differentially expressed

Gene

TP53 target 1

Gene

HOXA transcript antisense RNA, myeloid-specific 1

Gene

urothelial cancer associated 1

  • Gene

    SRC kinase signaling inhibitor 1


  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    PAX8 antisense RNA 1


  • Gene

    double homeobox A pseudogene 8


  • Gene

    CASTOR family member 3, pseudogene



  • Gene

    colorectal neoplasia differentially expressed



  • Gene

    HOXA transcript antisense RNA, myeloid-specific 1


  • Gene

    urothelial cancer associated 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.